# COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX)

> **NCT04409847** · — · COMPLETED · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 52 (actual)

## Conditions studied

- COVID
- Hypertension

## Interventions

- **DIAGNOSTIC_TEST:** ABPM
- **DIAGNOSTIC_TEST:** ECG
- **DIAGNOSTIC_TEST:** FMD
- **DIAGNOSTIC_TEST:** PWV
- **DIAGNOSTIC_TEST:** Rarefaction

## Key facts

- **NCT ID:** NCT04409847
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04409847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04409847, "COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04409847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*